.svg)
The Gap Between Clinical Trials and Real-World Chronic Wound Patients
Caroline Fife, M.D. highlights a concerning discrepancy between the characteristics of patients with chronic wounds in real-world settings and those selected for clinical trials.
All of us in wound care are struggling to understand the rationale for limiting patients to 4 applications of a skin substitute when the patients in the clinical trials used to rationalize “medically necessary” products (Group 2) were both healthier than “real world” patients and were given 10 or more applications to achieve closure.
Caroline Fife, M.D. highlights a concerning discrepancy between the characteristics of patients with chronic wounds in real-world settings and those selected for clinical trials. She stresses the potential implications this has for patient access to FDA approved treatments that have the potential to save limbs and lives. I think this is particularly apropos with the impending LCDs in CGS, First Coast, and Novitas.
Even if one were to ascribe to the theory that CMS does not have healing as it primary goal and instead is focused on cost containment, the costs of amputations and complications are likely far higher than more treatments. Once again Caroline’s blog is essential reading…
Read Caroline Fife, M.D.’s Blog The Realities of Chronic Wound Research here
Popular Posts
Categories
Wound Care Compliance & Audit Defense Essentials: Inside the Series Every Provider Should Be Watching
Venture Medical’s Wound Care Compliance & Audit Defense Essentials webinar series empowers clinicians and administrators to navigate today’s complex regulatory environment with clarity and confidence. Through expert-led sessions covering legal, billing, and investigative insights, the series helps providers stay compliant, reduce audit risk, and strengthen their practice for the future.
Running A Mobile Wound Practice With Confidence
Provider Jessica Hoge, MD shares how she’s streamlined her workflow, improved patient care, and eliminated frustration.
Avoiding wound care for free, a.k.a. surviving a “bad faith” audit.
Audits are meant to protect against fraud, but in wound care many providers are now facing aggressive “bad faith” audits driven by financial incentives and bias. This blog explores what’s behind the rise in these audits, their impact on patients and practitioners, and the steps providers can take to prepare, push back, and protect their practices.
The price patients will pay for the PFS
After a recent survey we conducted, it is clear most clinicians agreed skin substitutes are highly effective and essential, warning that the proposed rates would reduce patient access, hinder innovation, and threaten the viability of many practices. Read the blog to learn more about our findings.
